YTS109
/ BriSTAR Immunotech
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
May 19, 2025
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.
New P1 trial • ANCA Vasculitis • Genetic Disorders • Hematological Disorders • Immunology • Inflammation • Inflammatory Arthritis • Lupus • Myositis • Rheumatoid Arthritis • Rheumatology • Scleroderma • Sjogren's Syndrome • Systemic Lupus Erythematosus • Systemic Sclerosis • Vasculitis
May 13, 2025
A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus
(clinicaltrials.gov)
- P1 | N=36 | Recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Glomerulonephritis • Hematological Disorders • Immune Thrombocytopenic Purpura • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus • Thrombocytopenia • Thrombocytopenic Purpura
April 26, 2025
An Clinical Study of YTS109 Cell Injection in Subjects With Refractory Systemic Lupus Erythematosus
(clinicaltrials.gov)
- P1 | N=36 | Not yet recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.
New P1 trial • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus • Thrombocytopenia
January 13, 2025
A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia
(clinicaltrials.gov)
- P1 | N=7 | Not yet recruiting | Sponsor: Institute of Hematology & Blood Diseases Hospital, China
New P1 trial • Anemia • Autoimmune Hemolytic Anemia • Hematological Disorders • Immunology
August 27, 2024
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
(clinicaltrials.gov)
- P=N/A | N=6 | Recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • ANCA Vasculitis • Genetic Disorders • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Myositis • Scleroderma • Sjogren's Syndrome • Systemic Lupus Erythematosus • Systemic Sclerosis • Vasculitis
April 23, 2024
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
(clinicaltrials.gov)
- P=N/A | N=6 | Not yet recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.
New trial • ANCA Vasculitis • Fibrosis • Genetic Disorders • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Myositis • Scleroderma • Sjogren's Syndrome • Systemic Lupus Erythematosus • Systemic Sclerosis • Vasculitis
1 to 6
Of
6
Go to page
1